Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
96,489,844
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
78,709,574
-
Shares change
-
+5,280,954
-
Total reported value, excl. options
-
$827,347,590
-
Value change
-
+$46,727,000
-
Put/Call ratio
-
48%
-
Number of buys
-
86
-
Number of sells
-
79
-
Price
-
$10.51
Institutional Holders of AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL) as of Q4 2024
As of 31 Dec 2024 AVADEL PHARMACEUTICALS PLC - Common Stock (AVDL) had 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 78,709,574 shares of stock of the company.
Largest 10 holders included JANUS HENDERSON GROUP PLC, GENDELL JEFFREY L, BlackRock, Inc., Polar Capital Holdings Plc, Two Seas Capital LP, BRAIDWELL LP, VANGUARD GROUP INC, Vivo Capital, LLC, CITADEL ADVISORS LLC, and WEALTH EFFECTS LLC.
This table shows 153 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.